Preclinical data indicate GenSci098 has the potential to become a new treatment for Thyroid Eye Disease

This product will potentially enhance convenience and patient compliance

Under this agreement, TWi authorizes GenSci Singapore as the sole distributor of Megaxia? in mainland China, Hong Kong, Macau, and Singapore, responsible for the marketing and promotion of this product.

which marks the initiation of bioequivalence studies for the new formulation of Genakumab Injection

Jintrolong? PEG-SOMATROPIN was highlighted during the Growth Hormone Research Society (GRS) symposium at the largest endocrine event in Europe